Board Meeting20 Oct 2026, 12:24 pm
Orchid Pharma Eyes Up to ₹600 Cr Fundraising
AI Summary
Orchid Pharma Ltd's Board of Directors has passed an 'Enabling Resolution' to explore fundraising opportunities of up to ₹600 Crores. The funds can be raised through various instruments including equity shares, convertible debentures, qualified institutions placement, private placement, public issue of equity shares and/or debt securities, or preferential issue. This move is subject to necessary statutory, regulatory, and member approvals. The board meeting where this resolution was passed commenced at 11:00 AM IST and concluded at 11:50 AM IST on October 20, 2026.
Key Highlights
- Board approved an enabling resolution for fundraising.
- Company aims to raise up to ₹600 Crores.
- Fundraising can be via equity, debt, or convertible instruments.
- Various issuance modes like QIP, private placement are considered.
- Subject to regulatory and shareholder approvals.
Price Impact
More from ORCHPHARMA